Vision Capital Exits Terphane

Vision Capital is selling Terphane to publicly traded Tredegar Corp. for $188 million. Tredegar is a manufacturer of plastic films and aluminium extrusions. Terphane was the first investment from Vision Capital Partners VII L.P., the fund which closed in January 2009.

17 October 2011•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles